臓器保存の世界市場規模：保存技術別、臓器タイプ別、エンドユーザー別、地域別、範囲および予測

臓器保存の市場規模と予測

臓器保存市場規模は、2024年に2億5,934万米ドルと評価され、2026年から2032年にかけてCAGR 6.65%で成長し、2032年には4億1,424万米ドルに達すると予測されています。

臓器保存とは、移植や研究のために臓器の生存性と機能性を確保するための戦略や方法を指します。臓器はドナーから摘出された後、劣化を避け、レシピエントに移植されたときに適切に機能するよう、良好な状態に保たれなければならないため、この方法は極めて重要です。

臓器保存は移植医療において重要な技術であり、臓器を移植に耐えうる状態に保ち、機能させることを目的としています。臓器保存の主な用途には、肝臓、腎臓、心臓、肺、膵臓の移植があります。静的低温保存、低体温装置による灌流、常温装置による灌流など、さまざまな保存戦略が、輸送・保存中の臓器の生存性を高めるために用いられています。

臓器保存の将来は、技術的な飛躍的進歩と研究の進展により、有望であると思われます。生体保存や、より高温で臓器を生存させるための合成培地の使用といった新たな技術は、保存期間を延長し、臓器の質を向上させるために研究されています。

世界の臓器保存市場力学

主な市場促進要因

臓器移植率の増加：糖尿病、高血圧、肝臓病などの慢性疾患による臓器不全の頻度が高まるにつれ、臓器移植の需要も増加します。臓器移植を希望する人が増えるにつれ、効率的な臓器保存戦略の必要性が高まる。移植成功率の向上は、病院や医療施設が保存技術の強化に投資する動機となり、市場拡大の原動力となります。

保存技術の進歩：低体温器による灌流や凍結保存法の強化といった臓器保存技術の革新により、臓器の生存率が高まり、保存や輸送中の寿命が延びた。こうした開発により、移植が成功する可能性が高まり、保存技術はヘルスケア専門家にとってより魅力的なものとなっています。

政府の取り組みと意識向上プログラム：世界中の政府や組織は、臓器提供や臓器保存の価値をますます認識しつつあります。臓器提供に関する認識を高め、提供率を向上させ、より改善された臓器保存方法を導入する取り組みが一般的になりつつあります。このようなプログラムは、より多くの人々に臓器提供者としての登録を促すだけでなく、ヘルスケア環境における最新の臓器保存技術の使用を促進します。

主な課題

臓器の入手可能性の制限：臓器保存における最も大きな問題のひとつは、移植に適した臓器が不足していることです。臓器保存法の進歩にもかかわらず、臓器の需要と供給の間にはかなりの隔たりがあります。臓器提供者の資格、一般市民の知識、臓器提供に対する文化的見解などの要因が、この問題を悪化させています。

技術的限界：低温保存や低体温装置による灌流のような臓器保存技術は進歩しているが、まだ限界があります。これらの技術で臓器の生存期間を延長できるのは限られた期間だけであり、虚血や細胞損傷のリスクが高まる。

規制とコンプライアンスの問題：臓器保存産業は高度に規制されており、使用される技術や商品には厳格な基準が設けられています。これらの規制を乗り越えることは、企業にとって困難で時間のかかることであり、新技術の採用を遅らせ、運営コストを増加させる可能性があります。市場参入企業にとって、こうした基準を遵守することは非常に重要だが、特に中小企業にとっては難しいです。

主要動向：

技術の進歩：低体温マシン灌流や正常温熱局所灌流などの新しい臓器保存法は、移植用臓器の生存率を高めています。こうした革新的な手技は、臓器保存期間を延ばすだけでなく、移植後の臓器機能を向上させる。

臓器移植に対する需要の増加：糖尿病や肝硬変のような慢性疾患が一般的になるにつれ、臓器移植の需要が高まっています。臓器移植の待機者数が増えるにつれ、効果的な保存措置がますます重要になっています。この動向は、増大する需要を満たすため、臓器保存技術の改善に焦点を当てた研究開発への投資を後押ししています。

規制支援とイニシアチブ：政府や保健機関は、臓器提供や臓器移植を奨励するプログラムを立ち上げています。規制当局もまた、高度な臓器保存技術の使用を奨励するための規則を策定しています。こうした支援は、より優れた保存方法を可能にし、臓器の利用可能性を高めることで、臓器移植の全体像を改善します。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 臓器保存市場：保存技術別

• 概要
• 静的低温保存（SCS）
• 低体温マシン灌流（HMP）
• 常温機械灌流（NMP）

第5章 臓器保存市場：臓器タイプ別

• 概要
• 腎臓
• 肝臓
• 心臓
• 肺
• 膵臓
• その他

第6章 臓器保存市場：エンドユーザー別

• 概要
• 病院および移植センター
• 臓器調達機関（OPOs）
• 研究機関および研究所

第7章 地域別分析

• 概要
• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Overview
• XVIVO Perfusion
• TransMedics
• OrganOx Limited
• Franz Kohler Chemie GmbH
• Essential Pharmaceuticals LLC
• Preservation Solutions, Inc.
• BioLifeSolutions Inc.
• Bridge to Life Ltd.
• 21st Century Medicine
• Paragonix Technologies Inc

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Organ Preservation Market Size and Forecast

Organ Preservation Market size was valued at USD 259.34 Million in 2024 and is projected to reach USD 414.24 Million by 2032, growing at a CAGR of 6.65% from 2026 to 2032.

Organ preservation refers to the strategies and methods used to ensure the viability and functionality of organs for transplantation or study. This method is critical because organs must be kept in good condition after being removed from a donor to avoid deterioration and ensure they function properly when transplanted into a recipient.

It is a vital technique in transplantation medicine that aims to keep organs viable and functional for transplantation. The principal applications of organ preservation include liver, kidney, heart, lung, and pancreatic transplants. Various preservation strategies, including static cold storage, hypothermic machine perfusion, and normothermic machine perfusion are used to increase organ viability during transport and storage.

The future of organ preservation seems promising, thanks to technical breakthroughs and greater study. Emerging techniques such as biopreservation and the use of synthetic media to keep organs viable at higher temperatures are being investigated to prolong preservation times and improve organ quality.

Global Organ Preservation Market Dynamics

The key market dynamics that are shaping the global organ preservation market include:

Key Market Drivers:

Increasing Organ Transplantation Rates: As the frequency of organ failure from chronic diseases such as diabetes, hypertension, and liver disease rises so does the demand for organ transplants. As more people seek organ transplants, the necessity for efficient organ preservation strategies grows. Improved transplant success rates motivate hospitals and healthcare facilities to invest in enhanced preservation technologies which drives market expansion.

Advances in Preservation Technologies: Innovations in organ preservation technologies such as hypothermic machine perfusion and enhanced cryopreservation procedures have increased organ viability and longevity during storage and transport. These developments increase the likelihood of a successful transplant making preservation technology more enticing to healthcare professionals.

Government Initiatives and Awareness Programs: Governments and organizations around the world are increasingly realizing the value of organ donation and preservation. Initiatives to raise awareness about organ donation, increase donation rates, and introduce improved preservation procedures are becoming more common. Such programs not only encourage more people to register as organ donors but they also promote the use of modern preservation technology in healthcare settings.

Key Challenges:

Limited Availability of Organs: One of the most significant issues in organ preservation is the lack of suitable organs for transplantation. Despite advances in preservation procedures, there is still a considerable gap between organ demand and supply. Factors such as organ donor eligibility, public knowledge, and cultural views toward organ donation all worsen the problem.

Technological Limitations: Although organ preservation technologies like as cold storage and hypothermic machine perfusion have advanced, they are still limited. These techniques can only extend organ viability for a limited time increasing the risk of ischemia and cell damage.

Regulatory and Compliance Issues: The organ preservation industry is highly regulated with strict criteria governing the techniques and goods used. Navigating these restrictions can be difficult and time-consuming for businesses, potentially delaying the adoption of new technologies and increasing operational costs. Compliance with these standards is critical for market participants but it can be difficult, particularly for smaller companies.

Key Trends:

Technological Advancements: New organ preservation procedures such as hypothermic machine perfusion and normothermic regional perfusion are increasing the survivability of organs for transplantation. These innovative procedures not only increase the preservation period but also improve organ function after transplantation.

Increased Demand for Organ Transplants: As chronic diseases like diabetes and liver cirrhosis become more common, there is a greater demand for organ transplants. As waiting lists for organ transplants rise, effective preservation measures become increasingly important. This trend is pushing investment in R&D with a focus on improving organ preservation technologies to satisfy increasing demand.

Regulatory Support and Initiatives: Governments and health organizations are launching programs to encourage organ donation and transplantation. Regulators are also developing rules to encourage the use of advanced preservation technology. Such support improves the entire picture of organ transplantation by enabling better preservation methods and increasing organ availability.

Global Organ Preservation Market Regional Analysis

Here is a more detailed regional analysis of the global organ preservation market:

North America:

North America dominates the organ preservation market owing to its advanced healthcare infrastructure and high organ transplant rates. This dominance is reinforced by significant government financing, extensive research projects, and an established network of organ procurement groups. The United States leads in organ transplantation in North America, with the United Network for Organ Sharing (UNOS) reporting 41,354 organ transplants in 2021, up 5.9% from 2020.

According to data from the Organ Procurement and Transplantation Network (OPTN), there were 104,888 candidates on the national transplant waiting list in February 2023, highlighting the crucial need for organ preservation technology to maximize the viability of available organs. The U.S. Department of Health and Human Services reports that 17 people die each day waiting for an organ transplant emphasizing the urgency for advanced preservation methods to increase the pool of viable organs.

According to the Canadian Institute for Health Information, 2,782 organ transplants were performed in 2021, representing a 13% increase from 2020. The Canadian government has invested CAD 36.5 million over five years to improve the organ donation and transplantation system, which includes funding for preservation technologies.

Asia Pacific:

The rapidly increasing rate of organ transplants is the fastest-growing driver of the Asia Pacific organ preservation market. This acceleration is mostly owing to improved healthcare infrastructure, increased public awareness of organ donation, and government attempts to promote transplantation programs. In China, the number of organ transplants has significantly increased. The Commission also projected that the number of registered organ donors in China will reach 2.54 million by the end of 2020, up from 1,087 in 2010.

According to the National Organ and Tissue Transplant Organisation (NOTTO), the rate of organ donation in India has increased from 0.08 per million people in 2012 to 0.65 per million by 2021. Australia and New Zealand have also helped to drive regional growth, with the Australia and New Zealand Organ Donation Registry reporting 1,444 organ transplants in 2020, despite the pandemic's hurdles. These figures highlight the growing demand for effective organ preservation options in the Asia Pacific region. Furthermore, the World Health Organization estimates that the prevalence of chronic diseases, a primary driver of organ transplantation, will increase by 57% in the Asia Pacific region.

Global Organ Preservation Market: Segmentation Analysis

The Global Organ Preservation Market is segmented based on Preservation Technique, Organ Type, End-User, and Geography.

Organ Preservation Market, By Preservation Technique

• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP
• Normothermic Machine Perfusion (NMP)

Based on the Preservation Technique, the Global Organ Preservation Market is bifurcated into Static Cold Storage (SCS), Hypothermic Machine Perfusion (HMP, Normothermic Machine Perfusion (NMP). In the global organ preservation market, static cold storage (SCS) remains the dominant technique due to its widespread acceptance and established protocols for preserving organs before transplantation. SCS is cost-effective, simple to implement, and requires minimal equipment making it accessible for many hospitals and transplant centers. It is particularly effective for short-term preservation of organs such as kidneys and livers.

Organ Preservation Market, By Organ Type

• Kidneys
• Liver
• Heart
• Lungs
• Pancreas
• Others

Based on the Organ Type, the Global Organ Preservation Market is bifurcated into Kidneys, Liver, and Heart, Lungs, Pancreas, Others. In the global organ preservation market, the kidneys segment is the dominant category. This dominance is primarily due to the high prevalence of kidney diseases including chronic kidney disease and end-stage renal failure which necessitate organ transplants. The increasing number of dialysis patients seeking transplants amplifies the demand for kidney preservation solutions. Additionally, advancements in preservation technologies such as hypothermic machine perfusion, enhance the viability and longevity of kidney transplants, further propelling this segment's growth.

Organ Preservation Market, By End-User

• Hospitals and Transplant Centres
• Organ Procurement Organizations
• Research Institutes and Laboratories

Based on the End-User, the Global Organ Preservation Market is bifurcated into Hospitals and Transplant Centres, Organ Procurement Organizations, Research Institutes and Laboratories. In the global organ preservation market, hospitals and transplant centers are the dominant end-users. This dominance stems from their central role in the organ transplantation process where the preservation of organs is critical for successful outcomes. Hospitals and transplant centers are equipped with specialized facilities and expertise to ensure optimal preservation conditions facilitating the timely transplantation of harvested organs. Moreover, the increasing number of organ transplant procedures due to rising organ failure rates and advancements in transplantation technologies further drive the demand for preservation solutions in these settings.

Organ Preservation Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Organ Preservation Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is the dominant region in the global organ preservation market. This leadership is primarily attributed to advanced healthcare infrastructure, high rates of organ transplantation, and significant investments in research and development. The presence of key players and cutting-edge technologies further enhances the region's market position. Additionally, stringent regulations and standards governing organ preservation practices in North America drive innovation and ensure high-quality preservation solutions.

Key Players

The "Global Organ Preservation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are XVIVO Perfusion, TransMedics, OrganOx Limited, Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Preservation Solutions, Inc., BioLifeSolutions, Inc., Bridge to Life Ltd., 21st Century Medicine, and Paragonix Technologies, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Organ Preservation Market Key Developments

• In August 2022, Paragonix Technologies, Inc. achieved a critical milestone by preserving over 2,000 donor organs while delivering Advanced Organ Preservation (AOPT) technology and a statewide clinical support network. Each of these systems incorporates novel preservation methods, considerably improving traditional ice and cooler processes.
• In January 2023, transplant surgeons at MedStar Georgetown University Hospital in the Washington Metropolitan area of the United States successfully utilized a new FDA-approved technology, the OrganOx metra, which simulates connecting a liver to its recipient, allowing the donated liver to be preserved for up to 12 hours before being transplanted into the recipient.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Organ Preservation Market, By Preservation Technique

• Overview
• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP)
• Normothermic Machine Perfusion (NMP)

5. Organ Preservation Market, By Organ Type

• Overview
• Kidneys
• Liver
• Heart
• Lungs
• Pancreas
• Others

6. Organ Preservation Market, By End-User

• Overview
• Hospitals and Transplant Centers
• Organ Procurement Organizations (OPOs)
• Research Institutes and Laboratories

7. Regional Analysis

• Overview
• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Overview
• XVIVO Perfusion
• TransMedics
• OrganOx Limited
• Franz Kohler Chemie GmbH
• Essential Pharmaceuticals LLC
• Preservation Solutions, Inc.
• BioLifeSolutions Inc.
• Bridge to Life Ltd.
• 21st Century Medicine
• Paragonix Technologies Inc

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References